←Back to Expert Scholars
Translational Medicine / 转化医学Pan RAS Inhibitors
Trever Bivona
MD, PhD
🏢University of California San Francisco🌐USA
Professor
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Trever Bivona investigates drug tolerant persister cells and adaptive resistance to RAS and EGFR targeted therapy. His work identifies vulnerabilities exploitable by pan RAS inhibitors in combination with other agents. He leads translational programs in lung cancer precision medicine.
Share:
🧪Research Fields 研究领域
persister cells
RAS
lung cancer
adaptive resistance
precision oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Trever Bivona 的研究动态
Follow Trever Bivona's research updates
留下邮箱，当我们发布与 Trever Bivona（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment